What a parallel review can and cannot do
A review requested from China is a records-based opinion. A clinician looks at the diagnosis, imaging and treatment history you send, then comments on whether the current plan is reasonable, whether another option exists, and what information is still missing. It is not a transfer of care. It does not stop your local treatment, change your medicines, or reserve a bed.
This distinction matters for brain metastases because the disease is usually managed by more than one team. The primary cancer, the brain lesions, and any systemic treatment are often handled by different specialists who already coordinate with each other. A remote opinion adds one more perspective. It cannot replace the local team's ability to examine you, see new symptoms, or respond to a change in your condition.
So the honest framing is: a China review can answer a specific question, such as whether a different radiotherapy approach or a clinical trial is worth discussing. It cannot promise that a different option exists, that it is available in China, or that you should travel. Those answers belong to the receiving clinicians after they see your records.
The records that make a review worth doing
The quality of a records-based opinion depends almost entirely on what you send. For brain metastases, three record groups carry the most weight: the primary cancer history, the previous brain treatment, and the current local and systemic plan.
For the primary cancer, the receiving clinician needs the original pathology report, the stage at diagnosis, and any molecular or genomic results that guide treatment. A summary letter is helpful, but the original report is what a specialist reads. If the primary cancer was treated years ago, include that history even if it feels distant.
For the brain, include the imaging reports and, where possible, the actual images on disc or through a secure link. The report describes what the radiologist saw; the images let another clinician judge size, number, location and change over time. Previous brain treatment matters too: surgery, whole-brain radiotherapy, stereotactic radiosurgery, or any combination. The dates and the treated areas should be clear.
For current care, send the most recent clinic letters, the current medication list, and the plan your local team has proposed or started. If a decision is pending, say what the local team is deciding and by when. That single sentence often shapes the whole review.
A short cover note in English is useful. State the diagnosis, the main question, and what you want the review to address. You do not need to send a complete archive at first contact. Start with a brief summary, then share records through a secure route once the review is agreed.
Why the primary cancer history changes the brain question
Brain metastases are not one condition. The primary cancer type, its molecular profile, and how it has responded to previous treatment all shape what is reasonable for the brain. A lung cancer with a targetable mutation, a breast cancer with a known receptor status, and a melanoma with prior immunotherapy each raise different questions.
This is why a review that looks only at the brain images is incomplete. The receiving clinician needs to understand the whole disease. If the primary cancer is controlled and the brain lesions are the main problem, the discussion may focus on local control. If the systemic disease is active, the discussion may focus on whether a systemic option can also treat the brain.
The practical action is to ask your local team which documents best summarise the primary cancer and its treatment. Then send those, not everything. A focused file is easier to review and less likely to hide the key question.
What changed locally, and what you want the review to answer
Many patients seek a review because something changed: a new lesion, a scan that looked different, a recommendation to switch treatment, or a local plan that feels uncertain. Naming that change is the most useful thing you can do.
Write down the change in one or two sentences. For example: a new brain lesion appeared after previous radiosurgery, and the local team has recommended a different approach. Then write the question you want answered. For example: is the recommended approach consistent with the records, and is there another option worth discussing with my local team?
This framing keeps the review in its proper role. It does not ask the remote clinician to take over. It asks for a reasoned opinion that you can take back to the team that knows you. If the review raises an option, your local team decides whether it fits your situation and whether it can be delivered safely.
It also protects you from a common trap: treating a remote opinion as a decision. A remote clinician has not examined you, cannot see how you are responding, and cannot manage complications. The local team remains responsible for your day-to-day care.
Coordinating two opinions without pausing treatment
The safest pattern is simple: local treatment continues while the review is arranged. You do not need to pause anything to ask for a second opinion. If a local decision is urgent, make that decision with your local team first. A review can follow.
Tell your local team that you are seeking an additional opinion. Most clinicians accept this. It also means that if the review produces a useful question, you can raise it directly with the team that can act on it.
Keep one person responsible for collecting and sending records. If a family member is helping, agree who will communicate with the review service and who will speak with the local team. Mixed messages create delay.
Ask the review service what it needs, how it will share the opinion, and whether it will communicate with your local team. Some patients want the opinion sent to their local clinician; others prefer to read it first. Decide this before the review starts.
If you are considering travel to China, treat that as a separate question. A review does not establish that a hospital will accept you, that a treatment is available, or that travel is safe. Those points require direct confirmation from the receiving hospital and your local team.
- Keep local appointments and treatment as scheduled.
- Name one person to manage records and one to manage local communication.
- Ask how the opinion will be delivered and whether it can be shared with your local team.
- Separate the review question from any travel question.
Questions to ask before you send anything
Before you commit to a review, ask the service a few direct questions. What is the scope of the opinion? Who provides it? What records are needed? How long does the review take? What does it cost, and what is included? How will the opinion be shared?
For brain metastases, add two clinical questions. Will the reviewing clinician see the actual imaging, or only the reports? And will the opinion address the primary cancer as well as the brain lesions? If the answer to either is unclear, ask again before sending records.
You should also ask what the review cannot do. A records-based opinion cannot confirm eligibility for a trial, cannot guarantee hospital acceptance, and cannot replace an in-person assessment. If a service implies otherwise, that is a reason to slow down.
Finally, ask what happens after the opinion. If it raises an option, who discusses it with your local team? If it confirms the current plan, that is still useful information. A review that supports the local plan can reduce uncertainty.
A practical next step
Start with a short summary rather than a full archive. Describe the primary cancer, the brain treatment so far, the current local plan, and the one question you want answered. An initial enquiry is free and does not require buying a proxy consultation. If a review is appropriate, the team will explain what records to send and how to send them securely.
Keep your local team in the loop throughout. The goal is not to choose between two systems. It is to make sure the decision you and your local clinicians make is as well informed as it can be.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.